Arlington County’s new general obligation bond offering, headed for the market next month, has earned the highest possible rating from Fitch ratings.

Lees meer..

Eiwit belangrijk bij ontstaan van overgewicht en diabetes
Lees meer..

Kimberly-Clark schrapt 1.600 banen
Lees meer..

Nieuwe chemokuur met weinig bijwerkingen
Lees meer..

Once-yearly Aclasta® (zoledronic acid 5 mg)* has been approved in the European Union to treat men and postmenopausal women with osteoporosis caused by long-term use of glucocorticoids, commonly known as steroids.
Lees meer..

American Health Systems Corporation announced that Karl Gallegos, an authority on Drug Safety and Pharmacovigilance, is a partner with American HSC.
Lees meer..

Sandoz has received marketing authorization for the first-ever Japanese biosimilar, recombinant human growth hormone somatropin. The precedent-setting decision further reinforces Sandoz’s global leadership position in the rapidly-emerging market for biosimilars, or follow-on versions of existing state-of-the-art biopharmaceuticals.
Lees meer..

The National Association of Chain Drug Stores (NACDS) announced former U.S. Senate Majority Leader Tom Daschle (D-SD) as this year’s keynote speaker at the NACDS Pharmacy and Technology Conference. Senator Daschle will speak on Sunday, August 9, 2009, at the Business Program to be held from 8:00 to 9:30 a.m. “Senator Daschle is a healthcare expert,” commented NACDS President and CEO Steven C. Anderson, IOM, CAE.
Lees meer..

The National Association of Chain Drug Stores (NACDS) today announced that the 2009 NACDS Pharmacy & Technology Conference will provide a forum at which to provide further recognition to Leonard J. DeMino, RPh., a chain pharmacy icon whose resume already includes some of the industry’s highest honors and achievements. This news comes as DeMino announces his retirement as senior pharmacy consultant to NACDS, effective in June 2009.
Lees meer..

The U.S. Food and Drug Administration approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under. Plan B was first approved in 1999 for prescription use only for women of all ages. Plan B is manufactured by Duramed Pharmaceuticals Inc., of Cincinnati. In 2006, Plan B was approved for nonprescription use for women ages 18 and older.
Lees meer..